MAJOR SALIVARY GLANDS: Incisional biopsy, Excisional Biopsy, Resection

Specimen:
   Parotid gland:
    Superficial lobe only
    Deep lobe only
    Total parotid gland
   Submandibular gland
   Sublingual gland

Received:
Fresh
In formalin
Other (specify):

Procedure Type:
   Incisional biopsy
   Excisional biopsy
   Resection, parotid gland:
    Superficial parotidectomy
    Total parotidectomy
   Resection, submandibular gland
   Resection, sublingual gland
   Neck (lymph node) dissection (specify):
   Other (specify):
   Not specified

Specimen Integrity:
    Intact
    Fragmented

Specimen Size:
Greatest dimensions (cm):
Additional dimensions (if more than one part) (cm):

Specimen Laterality:
Right
Left
Bilateral
Not specified

Tumor Site:
   Parotid gland:
    Superficial lobe
    Deep lobe
    Entire parotid gland
   Submandibular gland
   Sublingual gland
   Other (specify):
   Not specified

Tumor Focality:
Single focus
Bilateral
Multifocal (specify):

Tumor Size:
Greatest dimension (cm):
Additional dimensions (cm):
Cannot be determined:

Tumor Description:
       Encapsulated/circumscribed
       Invasive
       Solid
       Cystic
       Other (specify):

Macroscopic Extent of Tumor (extent of invasion):

Histologic Type:
   Acinic cell carcinoma
   Adenoid cystic carcinoma
   Adenocarcinoma, not otherwise specified (NOS):
    Low grade
    Intermediate grade
    High grade
   Basal cell adenocarcinoma
   Carcinoma ex pleomorphic adenoma (malignant mixed tumor):
    Low-grade
    High-grade
    Invasive:
        Minimally invasive
        Invasive
    Intracapsular (noninvasive)
   Carcinosarcoma (true malignant mixed tumor)
   Clear cell adenocarcinoma
   Cystadenocarcinoma
   Epithelial-myoepithelial carcinoma
   Large cell carcinoma
   Low-grade cribriform cystadenocarcinoma
   Lymphoepithelial carcinoma
   Metastasizing pleomorphic adenoma
   Mucoepidermoid carcinoma:
    Low grade
    Intermediate grade
    High grade
   Mucinous adenocarcinoma (colloid carcinoma)
   Myoepithelial carcinoma (malignant myoepithelioma)
   Oncocytic carcinoma
   Polymorphous low-grade adenocarcinoma
   Salivary duct carcinoma
   Sebaceous adenocarcinomas:
    Sebaceous adenocarcinoma
    Sebaceous lymphadenocarcinoma
   Sialoblastoma
   Small cell (neuroendocrine) carcinoma
   Squamous cell carcinoma, primary
   Undifferentiated carcinoma, large cell type
   Other (specify):
   Carcinoma, type cannot be determined

Histologic Grade:
Not applicable
GX: Cannot be assessed
G1: Well differentiated
G2: Moderately differentiated
G3: Poorly differentiated
Other (specify):

Microscopic Tumor Extension:

Margins:
Cannot be assessed
Margins uninvolved by carcinoma, distance of tumor from closest margin: at
Margin(s) involved by carcinoma:

Treatment Effect:
    Not identified
    Present (specify):
    Indeterminate

Lymph-Vascular Invasion:
Not identified
Present
Indeterminate

Perineural Invasion:
Not identified
Present
Indeterminate

Lymph Nodes, Extranodal Extension:
Not identified
Present
Indeterminate

Pathologic Staging (pTNM)
TNM Descriptors:

m (multiple primary tumors)
r (recurrent)
y (post-treatment)

Primary Tumor (pT):
pTX: Cannot be assessed
pT0: No evidence of primary tumor
pT0: No evidence of primary tumor
pT1: Tumor 2 cm or less in greatest dimension without extraparenchymal extension
pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension without extraparenchymal extension
pT3: Tumor more than 4 cm and/or tumor having extraparenchymal extension
pT4a: Moderately advanced disease. Tumor invades skin, mandible, ear canal, and/or facial nerve.
pT4b: Very advanced local disease. Tumor invades skull base and/or pterygoid plates and/or encases carotid artery

Note: There is no category of carcinoma in situ (pTis) relative to carcinomas of salivary glands (major, minor).

Regional Lymph Nodes (pN):
pNX: Cannot be assessed
pN0: No regional lymph node metastasis ( 0 / )
pN1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension ( 1 / )
pN2a: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension ( 1 / )
pN2b: Metastasis in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension ( / )
pN2c: Metastasis in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension ( / )
pN3: Metastasis in a lymph node, more than 6 cm in greatest dimension ( / )

Size (greatest dimension) of the largest positive lymph node (cm):

Superior mediastinal lymph nodes are considered regional lymph nodes (level VII). Midline nodes are considered ipsilateral nodes.

Distant Metastasis (pM):
Not Applicable
pM1: Distant metastasis at

Additional Pathologic Findings:
       Sialadenitis
       Tumor associated lymphoid proliferation (TALP)
       Other (specify):

Ancillary Studies:

Treatment History:
       Neoadjuvant therapy:
        Yes (specify type):
        No
        Indeterminate
       Other (specify):

Comment(s):